Supraspinal modulation of pain by cannabinoids: The role of GABA and glutamate

72Citations
Citations of this article
122Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Recent physiological, pharmacological and anatomical studies provide evidence that one of the main roles of the endocannabinoid system in the brain is the regulation of γ-aminobutyric acid (GABA) and glutamate release. This article aims to review this evidence in the context of its implications for pain. We first provide a brief overview of supraspinal regulation of nociception, followed by a review of the evidence that the brain's endocannabinoid system modulates nociception. We look in detail at regulation of supraspinal GABAergic and glutamatergic neurons by the endocannabinoid system and by exogenously administered cannabinoids. Finally, we review the evidence that cannabinoid-mediated modulation of pain involves modulation of GABAergic and glutamatergic neurotransmission in key brain regions. © 2007 Nature Publishing Group All rights reserved.

Cite

CITATION STYLE

APA

Rea, K., Roche, M., & Finn, D. P. (2007, November). Supraspinal modulation of pain by cannabinoids: The role of GABA and glutamate. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0707440

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free